Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom | ACS Chemical Neuroscience
Mitragynine - Wikipedia
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects | Journal of Medicinal Chemistry
Kratom (Mitragyna speciosa) drug profile | www.emcdda.europa.eu
Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium? | Bentham Science
The secrets of kratom - Interview with Jay McLaughlin - Blossom
Scientists Just Solved a Major Piece of the Opioid Puzzle | WIRED
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site | eLife
Frontiers | Comparative Toxicity Assessment of Kratom Decoction, Mitragynine and Speciociliatine Versus Morphine on Zebrafish (Danio rerio) Embryos
Opioid-based plant might not be best solution for those seeking to curb habitual alcohol use - Purdue University News
The effects of kratom on restraint–stress-induced analgesia and its mechanisms of action - ScienceDirect
Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions | Scientific Reports
Kratom - Proteopedia, life in 3D
Translating Kratom-Drug Interactions: From Bedside to Bench and Back | Drug Metabolism & Disposition
Molecular docking evaluation of the alkaloids at the mu opioid... | Download Scientific Diagram
Central nervous system receptor binding data for mitragynine.... | Download Table
Receptor Selectivity and Therapeutic Potential of Kratom in Substance Use Disorders | Current Addiction Reports
Nature's first “atypical opioids”: Kratom and mitragynines - Raffa - 2018 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy | ACS Pharmacology & Translational Science
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency's scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse | FDA
Is Kratom the New 'Legal High' on the Block?: The Case of an Emerging Opioid Receptor Agonist with Substance Abuse Potential. | Semantic Scholar
Frontiers | The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for μ-Opioid Receptor and Opioid-Like Behavioral Effects in Rats | Journal of Pharmacology and Experimental Therapeutics
